Skip to main content

Table 4 Comparison of DCIS expression of ER, PR, and HER2 between BRCA1- and BRCA2-associated tumors

From: DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

 

BRCA1

BRCA2

Wilcoxon rank sum P value

ER intensity

  

<0.001

 0

32

7

 

 1

1

1

 

 2

4

6

 

 3

7

14

 

PR intensity

  

0.001

 0

31

9

 

 1

2

1

 

 2

4

6

 

 3

7

13

 

HER2 intensity

  

0.04

 0

31

14

 

 1

14

14

 

 2

1

1

 

 3

0

2

 
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us